The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+


Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

What is Neuromodulation?

Breaking News Share

Article Recounts Progress in Spinal Cord Stimulation

Aug. 18, 2017 - International Neuromodulation Society President Timothy Deer, MD, is quoted in an article about spinal cord stimulation (SCS). The article notes drawbacks of longterm opioid treatment, and says that with its technical advancements, SCS is poised to become a mainstay in chronic pain treatment. (Pain Medicine News)

Company Raises $18 Million in Public Offering

Aug. 17, 2017 - EnteroMedics, Inc. raised $18.1 million in a recent public preferred stock offering. (Mass Device)

Study of Deep Brain Stimulation in Post-Stroke Pain Showed Some Modulation of Mood

Aug. 16, 2017 - International Neuromodulation Society member Andre Machado, MD, PhD, presented results of a 10-patient prospective study of deep brain stimulation for post-stroke pain at the 2017 annual meeting of the American Association of Neurological Surgeons. Stimulation that targeted the affective, emotional aspect of pain led to a change in perception and emotion, but disability associated with pain remained unchanged. (Pain Medicine News)

Company Raises Funds to Study Low-Energy Transcranial Magnetic Stimulation for Treatment-Resistant Depression

Aug. 11, 2017 - NeoSync, Inc. has closed a $23 million Series D round of funding to finance a trial of its transcranial magnetic stimulation technology in treatment-resistant depression. The company's home-use device delivers low-energy, alternating magnetic field stimulation. (Fierce Biotech)


To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM